Article
New generation breast cancer cell lines developed from patient-derived xenografts
23 Jun 2020
Abstract excerpt
BACKGROUND: Breast cancer is a highly heterogeneous disease characterized by multiple histologic and molecular subtypes. While a myriad of breast cancer cell lines have been developed over the past 60 years, estrogen receptor alpha (ER)+ disease and some mutations associated with this subtype remain underrepresented. Here we describe six breast cancer cell lines derived from patient-derived xenografts (PDX) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
